LithoVision 2018

Biotech Stocks Near Massive Breakout - Investopedia (blog)

 
 
Investopedia (blog)Biotech Stocks Near Massive BreakoutInvestopedia (blog)The SPDR S&P Biotech ETF is nearing its all-time high at around $91, a level it has not seen since July 2015. The group fell hard in the summer and fall of 2015, as drug pricing took center stage during the 2016 U.S. election cycle, with fear that ...and moreá╗
 
Related NewsFeeds

Arizona State to grow human neurons, test treatments for neurodegenerative diseasesEurekAlert (press release)"There is much excitement about the potential of human pluripotent stem cells to treat nume

0 visits

Commit To Purchase AMAG Pharmaceuticals At $12, Earn 43.9% Annualized Using OptionsNasdaqInvestors considering a purchase of AMAG Pharmaceuticals, Inc. (Symbol: AMAG) stock, but tentative about paying

0 visits

Livingston DailyBrighton residents share how they lost weight, avoided diabetes in no-cost programLivingston DailyThat penchant for sweet treats, coupled with a lack of exercise, helped make Molitoris

0 visits

In-PharmaTechnologist.comUS FDA will take time to recover from shutdown but drug firm delays will be minimal says advocacy groupIn-PharmaTechnologist.comThe US Government shutdown only lasted one work

0 visits

Genetic Engineering & Biotechnology NewsClover Biopharmaceuticals Selects GE's FlexFactory Platform for New Facility in ChinaBioPharm InternationalClover Biopharmaceuticals, a company focused on d

0 visits

Cynata Executes MoU for Commercial Evaluation with Celularity, Inc.GlobeNewswire (press release)Celularity, Inc. was created through a deliberate combination of synergistic cellular medicine assets of

0 visits

New York sketches out $500M plan to build a biotech hubFierceBiotechOfficials envisage the site serving as an institutional anchor for the New York biotech community while also providing a space for e

0 visits

Endocrinology AdvisorAcute Kidney Injury Increases Risk for Postdischarge Hypoglycemia in DiabetesEndocrinology AdvisorHealthDay News - For hospitalized patients with diabetes, acute kidney injury (AK

0 visits

Understanding The Pros And Cons Of PRP & Biologic InjectionsBroadway WorldUnderstanding The Pros And Cons Of PRP & Biologic Injections Our ears perk up when we hear that one of our favorite profession

0 visits

Nigeria NewsFree Kroc Center health talk will spotlight diabetesFairfield Daily RepublicSolano County has one of the highest rates of the disease in the state, health officials report. The good news i

0 visits

U.S. Rare Earth Minerals, Inc. Initiates Direct E-Mail Ads to 1,700 ...GlobeNewswire (press release)PANACA, Nev., Jan. 23, 2018 (GLOBE NEWSWIRE) -- U.S. Rare Earth Minerals, Inc., (OTC-PINK:USMN) anno

0 visits

satPRnews (press release)Pharmacogenomics. Social, Ethical, and Clinical Dimensions ...satPRnews (press release)The Pharmacogenomics. Social, Ethical, and Clinical Dimensions Report has been published

0 visits

Battling depression with pharmacogenetics: Genetic screening could eliminate trial-and-error approach to medicationsGenetic Literacy ProjectFinding an antidepressant that works can be an agonizing per

0 visits

Researchers create first stem cells using CRISPR genome activationDrug Target ReviewIn a scientific first, researchers have turned skin cells from mice into stem cells by activating a specific gene in

7 visits

MilTechPharmacogenomics. Social, Ethical, and Clinical Dimensions - Biotechnology, Genomics, Healthcare IndustriesMilTechPharmacogenomics promises to revolutionize medicine by enabling the prevention,

8 visits

Celgene to buy Juno Therapeutics for $9bnPharmaceutical Business ReviewCelgene has signed an agreement to acquire integrated biopharmaceutical firm Juno Therapeutics for around $9bn. Under the deal, C

7 visits

Seasonal variation associated with gestational diabetes riskHealioWomen who are pregnant appear to be at increased risk for gestational diabetes during the summer months compared with winter months, b

0 visits

In-PharmaTechnologist.comApotex recalls metformin batch in AustraliaIn-PharmaTechnologist.comApotex has recalled a batch its diabetes drug APO-Metformin XR in Australia after a pill was plastic from a

0 visits

Researchers target African arrow poison for male birth controlIn-PharmaTechnologist.comScientists say a modified plant extract traditionally used as an arrow poison in eastern Africa could inhibit spe

0 visits

Spectrum Pharmaceuticals to Present Corporate Update at the Noble Capital Markets' Fourteenth Annual Investor ...Business Wire (press release)HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuti

0 visits

 
Semiconductor Analytics